- The patients less than 50 years: is there a need to lower the PSA cutoff point?
- Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
- Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH
- An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer
- Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
